Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I-M Wang

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Biological Chemistry|January 27, 1998
Interaction between the retinoid X receptor and transcription factor IIB is ligand-dependent in vivoG M Leong, K S Wang, M J Marton, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 1995
Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcriptionJ C Blanco, I M Wang, S Y Tsai, et al.
Blood|May 29, 2000
Vitamin A deficiency in mice causes a systemic expansion of myeloid cellsT Kuwata, I M Wang, T Tamura, et al.
ESMO Open|February 18, 2025
First-in-human phase I study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor activity of PF-07209960 in patients with advanced or metastatic solid tumorsA Naing, M McKean, L S Rosen, et al.
Journal of Viral Hepatitis|January 31, 2014
Gene expression analysis in serial liver fine needle aspiratesS Lejnine, M J Marton, I-M Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 2026
Lorlatinib versus crizotinib as first-line treatment for advanced ALK-positive non-small cell lung cancer: 7-year update from the phase 3 CROWN studyA T Shaw, B J Solomon, E Felip, et al.
ESMO Open|April 19, 2024
A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutationsJ Rodon, E Rodriguez, M L Maitland, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Biological Chemistry|January 27, 1998
Interaction between the retinoid X receptor and transcription factor IIB is ligand-dependent in vivoG M Leong, K S Wang, M J Marton, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 1995
Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcriptionJ C Blanco, I M Wang, S Y Tsai, et al.
Blood|May 29, 2000
Vitamin A deficiency in mice causes a systemic expansion of myeloid cellsT Kuwata, I M Wang, T Tamura, et al.
ESMO Open|February 18, 2025
First-in-human phase I study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor activity of PF-07209960 in patients with advanced or metastatic solid tumorsA Naing, M McKean, L S Rosen, et al.
Journal of Viral Hepatitis|January 31, 2014
Gene expression analysis in serial liver fine needle aspiratesS Lejnine, M J Marton, I-M Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 2026
Lorlatinib versus crizotinib as first-line treatment for advanced ALK-positive non-small cell lung cancer: 7-year update from the phase 3 CROWN studyA T Shaw, B J Solomon, E Felip, et al.
ESMO Open|April 19, 2024
A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutationsJ Rodon, E Rodriguez, M L Maitland, et al.
Pageof 2